Work

Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney disease

Year: 2019

Type: article

Source: Journal of Pharmaceutical and Biomedical Analysis

DOI: 10.1016/j.jpba.2019.06.033

Authors: Alexander J. Prokopienko, Raymond E. West, Jason R. Stubbs, Thomas D. Nolin

Institutions: University of Pittsburgh, University of Kansas Medical Center

Language: English

Topic: Dialysis and Renal Disease Management

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G2286830365, Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease, G666288050, Randomized, Controlled Pilot Study of Rifaximin Therapy in Chronic Kidney Disease, G9000096940, J. NRSA Training Core

OpenAlex ID: W2950249245

FWCI: 3.477

Cites: 21

Cited by: 32

Related to: 10